Noubar Afeyan, Ph.d.
Co-Founder Seres Therapeutics; Managing Partner and CEO, Fla
Therapeutics Serem
United Kingdom
Biography
Noubar Afeyan is Managing Partner and CEO of Flagship Pioneering. He is a recognized technologist and entrepreneur. He has more than 25 years of experience as an inventor, entrepreneur, CEO, and venture capitalist. Dr. Afeyan has co-founded and helped build numerous successful life sciences companies and technology startups. He was founder and CEO of PerSeptive Biosystems, a leader in the bio-instrumentation field. After PerSeptive's acquisition by Perkin Elmer/Applera Corporation in 1998, he was Senior Vice President and Chief Business Officer of Applera, where he initiated and oversaw the creation of Celera Genomics. Dr. Afeyan was also a founder, director, and investor in Chemgenetics Pharmaceuticals (acquired by Millennium Pharmaceuticals), Color Kinetics (acquired by Philips), and Adnexus Therapeutics (acquired by Bristol-Myers Squibb). Dr. Afeyan currently serves on a number of public and private company boards including Affinnova, BG Medicine, Pronutria, Joule Unlimited, and Moderna Therapeutics. He earned his Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987.
Research Interest
Business and Management.
